Fortrea
Driving Productivity in Biotech Clinical Trials
In this series, we discuss how to drive productivity in biotech clinical trials and how to maximize valuation for minimal investment. Historically, R&D productivity has always been an area of focus and priority for the industry, but recent trends are particularly challenging. How do you realize this ultimate goal as protocols are becoming increasingly complex?
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Collaboration Between Contract Research Organizations and Biotech Companies 11.08.2025 10:49
Wrap up our Driving Productivity in Biotech Clinical Trials podcast as we discuss collaboration between Contract Research Organizations and biotech companies, emphasizing the importance of communication and understanding in clinical trials. Participants: Host: Dr. Ken Park, VP of R&D Strategy and Innovation Consulting for Fortrea Tracy Newbold, VP of Clinical Operations at Lexicon Pharmaceuticals...
Innovative Approaches to Enhance Productivity 11.08.2025 21:05
This episode explores innovative approaches to enhance productivity within clinical trials, focusing on the use of technology and data-driven strategies. Participants: Host: Dr. Ken Park, VP of R&D Strategy and Innovation Consulting for Fortrea Tracy Newbold, VP of Clinical Operations at Lexicon Pharmaceuticals Terry Athreya, SVP and Global Head of Clinical Operations for Fortrea Alaric Jackson, C...
How to Maximize Valuation for Minimal Cost 11.08.2025 20:42
In this episode, “How to Maximize Valuation for Minimal Cost,” we explore a critical question: Are you focused on regulatory approval, or on maximizing value? Your answer could determine the path your clinical trial takes, and the outcome it delivers. Participants: Host: Dr. Ken Park, VP of R&D Strategy and Innovation Consulting for Fortrea Tracy Newbold, VP of Clinical Operations at Lexicon Pharm...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.